Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $21.33 USD
Change Today +0.28 / 1.33%
Volume 120.6K
OSIR On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Philip R. Jacoby Jr.

Chief Financial Officer, Treasurer and Corporate Secretary, Osiris Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

62$244,329
As of Fiscal Year 2014

Background*

Mr. Philip R. Jacoby, Jr. has been Chief Financial Officer, Company Secretary and Treasurer of Osiris Therapeutics, Inc. since July 2009, November 2007 and May 2010 respectively. Mr. Jacoby is responsible for all financial and SEC reporting matters and is deeply involved in contract negotiations and budgets. He served as Chief Accounting Officer of Osiris Therapeutics, Inc. since May 2005 and also served as its Vice President of Finance since July 2008. He served as ...

Read Full Background

Corporate Headquarters*

7015 Albert Einstein Drive
Columbia, Maryland 21046

United States

Phone: 443-545-1800
Fax: 443-545-1701

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
University of Maryland

Other Affiliations*

Annual Compensation*

Salary$216,417
Bonus$25,000
Total Annual Compensation$241,417

Stock Options*

All Other Compensation$2,912
Exercised Options15,947
Exercised Options Value$128,833
Exercisable Options49,181
Unexercisable Options30,000
Total Value of Options$128,833
Total Number of Options95,128

Total Compensation*

Total Annual Cash Compensation$244,329
Total Short Term Compensation$241,417
Other Long Term Compensation$2,912
Total Calculated Compensation$244,329
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSIR:US $21.33 USD +0.28

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$884.3K
James Patrick Mackin Chairman of the Board, Chief Executive Officer and President
CryoLife Inc.
$421.6K
Edward Joseph Quilty BA,MBAChairman, Chief Executive Officer and President
Derma Sciences Inc.
$530.0K
Thomas Axelsson M.Sc.Chief Executive Officer
Vitrolife AB (publ)
kr4.0M
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
$469.9K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSIRIS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.